Article
Promoter hypomethylation upregulates ANXA2 expression in pancreatic cancer and is associated with poor prognosis.
2022-11-29
Abstract excerpt
Pancreatic cancer (PC) is one of the world's most aggressive and deadly cancers, owing to non-specific early clinical symptoms, late-stage diagnosis, and poor survival. Therefore, it is critical to identify specific biomarkers for its early diagnosis. Annexin A2 (ANXA2) is a calcium-dependent phospholipid-binding protein that has been reported to be up-regulated in several cancer types, making it an emerging bioma...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b7f685f0-444e-5966-825b-796cd3a26496
- DOI
- 10.21203/rs.3.rs-2306538/v1
